Your browser doesn't support javascript.
loading
Catastrophic health expenditure of Vietnamese patients with gallstone diseases - a case for health insurance policy revaluation.
Tran, Bach Xuan; Tran, Tho Dinh; Nathan, Nila; Ngo, Chau Quy; Nguyen, Loi Thi; Nguyen, Long Hoang; Nguyen, Huong Lan Thi; Nguyen, Cuong Tat; Do, Huyen Phuc; Nguyen, Trang Huyen Thi; Tran, Tung Thanh; Thai, Thao Phuong Thi; Dang, Anh Kim; Nguyen, Nam Ba; Latkin, Carl A; Ho, Cyrus S H; Ho, Roger C M.
Afiliação
  • Tran BX; Department of Health Economics, Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.
  • Tran TD; Department of Health, Behavior and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Nathan N; Department of Hepatobiliary Surgery, Vietnam-Germany Hospital, Hanoi, Vietnam.
  • Ngo CQ; University of California, Santa Barbara, Santa Barbara, CA, USA.
  • Nguyen LT; Department of Internal Medicine, Hanoi Medical University, Hanoi, Vietnam.
  • Nguyen LH; Woolcock Institute of Medical Research Vietnam, Hanoi, Vietnam.
  • Nguyen HLT; Center of Excellence in Behavioral Medicine, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam.
  • Nguyen CT; Institute for Global Health Innovations, Duy Tan University, Danang, Vietnam, kimanh.ighi@gmail.com.
  • Do HP; Institute for Global Health Innovations, Duy Tan University, Danang, Vietnam, kimanh.ighi@gmail.com.
  • Nguyen THT; Center of Excellence in Behavioral Medicine, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam.
  • Tran TT; Center of Excellence in Evidence-based Medicine, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam.
  • Thai TPT; Center of Excellence in Evidence-based Medicine, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam.
  • Dang AK; Department of General Planning, Friendship Hospital, Hanoi, Vietnam.
  • Nguyen NB; Department of Cardiology, Friendship Hospital, Hanoi, Vietnam.
  • Latkin CA; Institute for Global Health Innovations, Duy Tan University, Danang, Vietnam, kimanh.ighi@gmail.com.
  • Ho CSH; Center of Excellence in Behavioral Medicine, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam.
  • Ho RCM; Department of Health, Behavior and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Clinicoecon Outcomes Res ; 11: 151-158, 2019.
Article em En | MEDLINE | ID: mdl-30804677
ABSTRACT

PURPOSE:

Despite gallstone diseases (GSDs) being a major public health concern with both acute and chronic episodes, none of the studies in Vietnam has been conducted to investigate the household expenditure for the GSD treatment. The objective of this study was to estimate the costs of managing GSD and to explore the prevalence and determinants of catastrophic health expenditure (CHE) among Vietnamese patients. MATERIALS AND

METHODS:

A cross-sectional study was conducted from June 2016 to March 2017 in the Department of Hepatobiliary and Pancreatic Surgery, Viet Duc Hospital in Hanoi, Vietnam. A total of 206 patients were enrolled. Demographic and socioeconomic data, household income, and direct and indirect medical costs of patients seeking treatment for GSD were collected through face-to-face interview. Multivariate logistic regression was used to explore factors associated with CHE.

RESULTS:

The prevalence of CHE in patients suffering from GSD was 35%. The percentage of patients who were covered by health insurance and at risk for CHE was 41.2%, significantly higher than that of those noninsured (15.8%). Proportions of patients with and without health insurance who sought outpatient treatment were 30.6% and 81.6%, respectively. Patients who were divorced or widowed and had intrahepatic gallstones were significantly more likely to experience CHE. Those who were outpatients, were women, had history of pharmacological treatment to parasitic infection, and belong to middle and highest monthly household income quantile were significantly less likely to experience CHE.

CONCLUSION:

The findings suggested that efforts to re-evaluate health insurance reimbursement capacity, especially for acute diseases and taking into account the varying preferences of people with different disease severity, should be conducted by health authority. Further studies concerning CHE of GSD in the context of ongoing health policy reform should consider utilizing WHO-recommended measures like the fairness in financial contribution index, as well as taking into consideration the behavioral aspects of health care spending.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude Tipo de estudo: Health_economic_evaluation / Observational_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Clinicoecon Outcomes Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Vietnã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude Tipo de estudo: Health_economic_evaluation / Observational_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Clinicoecon Outcomes Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Vietnã
...